Browse the evidence

The central nervous system (CNS) integrates peripheral adiposity signals (insulin and leptin) and gastrointestinal signals (GLP-1) to regulate both energy balance and glucose homeostasis through overlapping hypothalamic mechanisms.

Your brain acts as a command center for metabolism, listening to hormones like insulin and leptin to decide how to store or burn energy. If these signals are ignored or misinterpreted by the brain (CNS dysfunction), it can lead to obesity and type 2 diabetes, regardless of peripheral efforts.

Hypothalamic AMPK and mTOR act as fuel sensors that integrate energy status signals to regulate food intake and energy expenditure.

Your brain uses molecular sensors (AMPK and mTOR) to detect energy availability. When these sensors are activated or inhibited by nutrients or hormones, they adjust your hunger and energy expenditure.

Beta-adrenergic blockade via propranolol significantly reduces glucose-induced thermogenesis (GIT) in healthy humans, indicating that approximately 30% of the thermogenic response to glucose is mediated by the sympathetic nervous system.

Your body uses your sympathetic nervous system to burn extra calories when you eat, specifically in response to carbohydrates. This 'thermic effect' is not just the mechanical cost of storing food; about 30% of it is an active, regulated process driven by adrenaline-like signals. Blocking this pathway (e.g., with beta-blockers) reduces your ability to burn these excess calories, potentially contributing to weight gain or making weight loss harder.

Self-reported dietary monitoring is highly inaccurate, with estimations ranging from 50% under to 50% over actual intake, making it an unreliable tool for weight management.

Stop relying on your memory to track what you eat. Self-reports are notoriously inaccurate, often missing half the calories you consume. To manage weight effectively, you need objective data, not estimates.

Nuclear translocation of Perilipin 5, triggered by catecholamine-induced PKA phosphorylation, integrates lipid droplet lipolysis with mitochondrial biogenesis by forming transcriptional complexes with PGC-1α and SIRT1 to promote fatty acid catabolism.

This research explains how your body coordinates fat burning with energy production during stress or fasting. When you engage in activities that trigger adrenaline (like exercise or fasting), your body doesn't just burn fat; it simultaneously builds the mitochondrial machinery to handle that fat. This suggests that combining metabolic stressors (like fasting with exercise) may optimize metabolic efficiency by leveraging this natural coordination mechanism.

Higher maternal intake of protein and fat during pregnancy is associated with higher offspring intake of the same nutrients at age 10, suggesting in utero programming of appetite.

Maternal nutrition during pregnancy, specifically protein and fat intake, appears to influence the child's appetite and food preferences later in life. While this does not mean parents should restrict these nutrients, it suggests that a balanced, nutrient-dense diet during pregnancy may help establish healthier eating patterns in the child.

Menopause increases the risk and severity of OSA in women due to the loss of protective hormonal effects (progesterone) and changes in fat distribution.

If you are postmenopausal and experiencing new sleep issues, snoring, or fatigue, ask about sleep apnea. The protective effect of female hormones decreases after menopause, significantly increasing your risk. It is not just 'part of aging' and is treatable.

Aging is associated with reduced SIRT1 activity, which leads to decreased pVHL levels and subsequent stabilization of HIF-1α, resulting in impaired mitochondrial biogenesis and functional decline.

As you age, your body's ability to regulate oxygen-sensing pathways (specifically the SIRT1-pVHL-HIF-1α axis) changes, leading to reduced mitochondrial efficiency. While you cannot directly 'dose' this mechanism, understanding that this is a natural part of aging helps contextualize fatigue and metabolic changes. Interventions like caloric restriction or compounds like resveratrol are mentioned as potential ways to support SIRT1 activity, but the primary takeaway is that this is a complex, multi-factorial biological process.

Intermittent hypoxia (such as from Obstructive Sleep Apnea) activates NFκB and inflammatory mediators like TNF-α without sufficiently stabilizing HIF-1α, leading to chronic inflammation and disease progression.

If you have Obstructive Sleep Apnea (OSA), the intermittent drops in oxygen do not trigger the protective HIF-1α response seen in sustained hypoxia. Instead, they trigger inflammation (NFκB/TNF-α), which accelerates aging and disease. Treating OSA (e.g., with CPAP) is crucial to reducing this inflammatory burden.

Activation of AMPK during hypoxia and aging promotes mitochondrial biogenesis via PGC-1α and inhibits chronic inflammation by suppressing NFκB, thereby extending healthspan.

Activating AMPK (through exercise, caloric restriction, or compounds like metformin) supports mitochondrial health and reduces chronic inflammation. This is a key mechanism for extending healthspan and preventing age-related diseases.

Prolonged sitting in specific contexts (TV-viewing or occupational sitting) does not show a significant association with all-cause or cardiometabolic mortality in the short term (3.3 years), unlike total sitting time.

Don't panic about watching TV or sitting at work specifically. Focus on reducing your total hours of sitting throughout the entire day.

Exposure to environmental obesogens (e.g., tributyltin, BPA, phthalates) increases susceptibility to obesity by altering developmental programming of stem cells and metabolic regulation, independent of caloric intake.

Minimize exposure to known obesogens like BPA (plastics), phthalates, and organotins (marine contaminants, PVC pipes). Use glass or stainless steel containers, avoid heating food in plastic, and choose fresh over processed foods to reduce intake of additives and packaging leachates, especially during pregnancy and early childhood.

Genetic susceptibility to common obesity is distributed across a mosaic of specific neuronal cell types in the brain (including hypothalamus, midbrain, and cortex) rather than being driven by a single canonical energy homeostasis circuit.

This research suggests that obesity is not caused by a single broken part in the brain but involves a complex network of neurons across multiple regions. This implies that treatments targeting only one area (like the hypothalamus) might be insufficient for everyone, and future therapies may need to address this broader neural network.

During the initial energy restriction phase of a weight loss program, adipose tissue macrophage gene expression is upregulated, which correlates with lower improvements in insulin sensitivity, whereas during subsequent weight stabilization, macrophage gene expression is downregulated and associated with improved insulin sensitivity.

If you are undertaking a significant weight loss program, be aware that the initial rapid weight loss phase (energy restriction) triggers a distinct inflammatory response in fat tissue (upregulation of macrophage genes) that may temporarily blunt improvements in insulin sensitivity compared to the later stabilization phase. This does not mean the weight loss is ineffective, but it highlights that the body's molecular response evolves over time. Consistency through the stabilization phase is crucial for resolving this inflammatory state and maximizing metabolic health benefits.

Fetal malnutrition (low birth weight) combined with postnatal caloric abundance causes irreversible metabolic programming (thrifty phenotype) that predisposes individuals to insulin resistance and obesity in adulthood.

If you were born small or experienced early childhood malnutrition, your body may be biologically programmed to store fat aggressively when food is abundant. Focus on environmental controls (food availability) and early childhood nutrition rather than relying solely on adult willpower.

Tribulus Terrestris supplementation does not improve muscle strength, body composition, or testosterone levels in trained individuals, despite marketing claims to the contrary.

Do not take Tribulus Terrestris expecting it to increase your testosterone or muscle strength. Research shows it has no effect on these metrics in trained individuals. It is likely a waste of money, though it may have a placebo effect.

Creatine ethyl ester (CEE) is less stable than creatine monohydrate in acidic environments and does not promote greater muscle creatine gains or training adaptations compared to CM.

Avoid creatine ethyl ester. It breaks down in your stomach and doesn't work better than regular creatine monohydrate.

In obese, insulin-resistant individuals, skeletal muscle mitochondria exhibit increased reactive oxygen species (ROS) production and lower abundance of Complex I subunits and CPT1B protein, despite maintaining normal maximal mitochondrial respiration rates.

For obese, insulin-resistant individuals, the problem isn't that your mitochondria can't burn fat (maximal capacity is normal), but that they are leaking harmful ROS and have lower levels of key fat-burning entry proteins (CPT1B). This suggests focusing on strategies that reduce oxidative stress and improve mitochondrial efficiency rather than just 'boosting capacity'.

Mitochondria from insulin-resistant muscle maintain higher thermodynamic driving forces (more negative static head ATP free energy) at low metabolic flux, which predicts higher ROS production.

At rest, your mitochondria are holding a stronger 'charge' (higher ATP free energy) than lean individuals. This high-energy state drives more electron leakage (ROS), which may contribute to insulin resistance.

Insulin-resistant skeletal muscle exhibits significantly lower abundance of Carnitine Palmitoyltransferase 1B (CPT1B) and specific Complex I subunits, which may contribute to lipid accumulation.

Obese, insulin-resistant individuals have less of the protein (CPT1B) that shuttles fat into mitochondria for burning. This bottleneck may cause fat to accumulate in the muscle, worsening insulin resistance.

Rapamycin has symptomatic, aging-independent effects on cognitive function and motor activity in mice, improving performance in young and old animals alike.

Rapamycin may improve cognitive and motor function in mice regardless of age, suggesting symptomatic benefits. However, this does not equate to slowing aging. Human application for cognitive enhancement remains experimental and carries immunosuppression risks.

Low free testosterone levels predict increased mortality from cardiovascular disease (CVD) in older men, whereas low testosterone is not associated with mortality from other causes.

For older men, low free testosterone is a specific warning sign for heart-related death risk, not necessarily for all causes of death. While this suggests checking hormone levels might help assess cardiovascular risk, it does not support using testosterone therapy as a general anti-aging or longevity treatment. Focus on cardiovascular health markers rather than assuming low T alone dictates lifespan.

In urban food deserts, increasing geographic proximity to full-service supermarkets does not significantly improve dietary quality or reduce BMI because residents already travel outside their neighborhoods to access healthy food.

If you live in a food desert, building a supermarket nearby is unlikely to change your diet or weight because you are already traveling to supermarkets. Focus on interventions that support the existing behavior of traveling to healthy stores (e.g., transportation subsidies, loyalty programs) rather than just building new stores.

Maintaining a body weight 10% below usual increases skeletal muscle work efficiency and shifts fuel utilization toward fatty acids at low exercise intensities (10-25 W) by decreasing glycolytic enzyme activity (PFK) relative to oxidative capacity, without changing mitochondrial density or fiber type.

When you lose weight, your body becomes more efficient at moving, especially during light activities like walking or slow cycling. This means you burn fewer calories for the same amount of light activity than you did before. To maintain your new weight, you may need to be mindful of your diet and ensure you are getting enough physical activity, as your body's 'default' efficiency has increased to conserve energy.